Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Kreepa Kooblall

BSc (Hons), PhD

Postdoctoral researcher

Marshall-Smith Syndrome (MSS) is a congenital disorder affecting skeletal and neural development due to mutations in the nuclear factor I/X (NFIX) gene. These mutations introduce frame shifts and splice site variants, which result in the production of aberrant transcripts, leading to the production of dysfunctional mutant NFIX proteins. NFIX is a transcription factor that regulates gene expression in many tissues, including lung, kidney, liver, blood, heart, skeleton and nervous system. It binds as homo- or hetero- dimers to the promoter regions of genes where it can act as either a suppressor or activator of gene transcription.

My postdoctoral research focuses on understanding the role of NFIX in the pathogenesis of Marshall-Smith Syndrome and to identify potential treatments for MSS by using a wide range of basic molecular and cellular biology techniques such as cloning techniques, PCR, RT-qPCR, RNA sequencing, western blot, immunohistochemistry, cell culture, cell transfections, microscopy and in vitro expression and reporter assays. My work predominantly focuses on (i) elucidating the mechanisms of action of MSS-associated NFIX mutations on NFIX activity in order to gain greater insight into the role of MSS-associated NFIX mutations in bone development; (ii) identifying pathways that are differentially altered by the MSS-associated NFIX mutations which may represent potential targets for drugs; (iii) identifying compounds that could modulate NFIX activity; and (iv) assessing the efficacy of compounds at modulating NFIX activity and their use as possible treatments for MSS. Prior to starting my postdoctoral work in Oxford, I completed an undergraduate degree in Biological Sciences (Genetics) from the University of Birmingham and a PhD in Genetics from the University of Cambridge, where I investigated pathways and mechanisms of epigenetics and RNA interference. I am a member of the Genetics Society and the Society for Endocrinology.

Recent publications

More publications